Cerebrovascular accidents (CVA), commonly known as strokes, continue to be a leading cause of morbidity and mortality in healthcare institutions. As pharmacists, staying informed about the latest trends in the management of CVA is essential to improve patient outcomes and contribute to reducing the impact of this critical condition.
This virtual Continuing Professional Development (CPD) training event has been designed to equip participants with the latest knowledge in the pharmacotherapy and management of stroke. Facilitated by distinguished experts with extensive experience in the field, this program will delve into the intricacies of stroke treatment, including the differentiation between types of strokes and the appropriate pharmacological approaches for each.
In addition to comprehensive presentations, participants will have the opportunity to engage in a highly interactive Q&A session, allowing for the clarification of complex topics and the exchange of best practices. Make a date with us and equip yourself with the knowledge to make informed decisions in the management of CVA. This training will not only enhance your professional competence but also uplift the care provided to stroke patients.
WHY YOU SHOULD ATTEND
this training will provide you with valuable insights into the latest trends and evidence-based practices in CVA management, helping you enhance your understanding of the pharmacological approaches for both ischemic and hemorrhagic strokes. You'll benefit from the expertise of leading professionals in the field and have the opportunity to engage in a dynamic Q&A session, where practical solutions to real-world challenges will be discussed.
ORGANIZED BY
PROUDLY SPONSORED BY
This is a virtual event will take place on Thursday the 19th of September 2024 at 17:00 GMT.
Event Moderator: Pharm. Samuel Owusu (National Vice-Chairman of GHOSPA & Chairman, GHOSPA CPD Committee)
Chairperson: Pharm. Dr. Emmanuel O. Owiafe (National Chairman of GHOSPA)
Target Audience: Pharmacists
Date: Thursday, 19th September 2024
Time: 17:00 GMT (5:00 PM Local Time)
AGENDA
Opening Prayer – Moderator
Welcome Remarks by CPD Chairman – Pharm. Samuel Owusu
Remarks by GHOSPA Chairman – Dr. Emmanuel O. Owiafe
Presentation 1: From Introduction to Non-pharmacological Treatment – Dr. Emmanuel Sarkodie
Presentation 2: Pharmacotherapy – Dr. Marc Kwame Dzradosi
Q&A Session – Moderator / Resource Persons
Closing Remarks & Vote of Thanks – Moderator
This virtual CPD training, organized by GHOSPA, will provide pharmacists with up-to-date knowledge on the current trends in the management of cerebrovascular accidents (CVA), with a focus on pharmacotherapy. Facilitated by highly experienced professionals, the session will cover key aspects of stroke management, including the differentiation between hemorrhagic and ischemic strokes, alternative medications for ischemic stroke, and recommended pharmacotherapy. Participants will also engage in a dynamic Q&A session, gaining practical insights to improve their clinical practice and patient outcomes.
By the end of this training, participants will be able to:
1. Differentiate between the different types of stroke (haemorrhagic and ischemic).
2. Know the alternative medications for ischemic stroke.
3. Recommend the best pharmacotherapy for ischemic stroke.
4. Understand the role of non-pharmacological treatments in stroke management.
5. Evaluate emerging therapies and their potential applications in clinical practice.
Pharm.D, FGCPharm, MPSGh.
Clinical Pharmacy Specialist / Lecturer
Head of Pharmaceutical Services – International Maritime Hospital.
Dr Marc K. Dzradosi has over fifteen (15) years’ experience in Hospital based Clinical Pharmacy Services, Academia, Research, Healthcare Administration, Public Health, Nutrition, and Exercise Science.
View full profile / coursesBPharm, PharmD, FGCPharm, FPCPharm
Director of Pharmacy/Specialist Pharmacist/Clinical Pharmacy Lecturer
KNUST Hospital, Kumasi
Dr. Emmanuel Sarkodie is a highly skilled Clinical Pharmacy Specialist and Lecturer, recognized for his versatility in adapting to the complexities of the healthcare industry. As a dedicated pharmacist, he is committed to delivering exceptional pharmaceutical care, focusing on disease management and improving patient outcomes.
View full profile / courses